3D Tissue Culture with SHH Gradients for Brain Topography

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current brain organoid technologies lack topographic organization, which is crucial for establishing precise neuronal connectivity, as they do not replicate the graded signaling activity of Sonic Hedgehog (SHH) observed in vivo, leading to haphazard neuronal connectivity.

Innovation Solution

Application of a concentration gradient of Sonic Hedgehog (SHH) protein to promote topographic organization in three-dimensional tissue culture by creating an organizer/aggregate complex with inhibitors like BMP, TGFβ/Activin-Nodal, and Wnt inhibitors, allowing for the formation of distinct brain regions in anatomically correct positions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If uniform signaling activity is used throughout the tissue, then the protocol is simple to implement, but the topographic organization is lost

Engineering Contradiction:
Improveprotocol simplicityVSAvoidtopographic organization
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent applies local quality by creating spatially heterogeneous signaling environments within the organoid. Different regions of the tissue are exposed to different concentrations of signaling molecules (e.g., SHH gradient from ventral to dorsal regions), allowing each local area to develop distinct cellular identities and functions that mirror in vivo topographic organization.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent introduces asymmetry by breaking the uniform signaling distribution through symmetry-breaking events. This is achieved by locally expressing signaling molecules at specific positions (e.g., SHH expression at the ventral midline) to establish asymmetric concentration gradients that define anterior-posterior, dorsal-ventral, and medio-lateral axes, thereby creating topographically organized brain regions.

Inventive Principle:
Principle #4Asymmetry

2Manufacturing precision

If bath-applied soluble proteins are used to restrict tissue identity, then specific brain sub-regions can be targeted, but the graded asymmetric signaling activity is lost

Engineering Contradiction:
Improvetissue identity specificationVSAvoidsignaling gradient establishment
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent employs self-service by enabling the tissue itself to generate the required signaling gradients through localized expression of signaling molecules. Rather than externally applying complex gradient patterns, the system uses endogenous gene expression (e.g., SHH transgenic lines) combined with physical constraints (e.g., microfabricated chambers, hydrogel matrices) to allow the tissue to autonomously establish the necessary concentration gradients for topographic organization.

Inventive Principle:
Principle #25Self-service

3Stability of the object's composition

If no symmetry-breaking event is applied, then the protocol maintains tissue symmetry, but the three body axes cannot be specified

Engineering Contradiction:
Improvetissue symmetryVSAvoidaxis specification
Core Design Contradiction:
Stability of the object's compositionVSManufacturing precision

Solution Approach 1:

The patent applies preliminary action by pre-establishing the structural and biochemical framework necessary for symmetry breaking before differentiation begins. This includes pre-forming the tissue aggregate with appropriate cell type composition, pre-positioning signaling molecule sources (e.g., transgenic cells, implanted beads), and pre-configuring the physical environment (e.g., microfluidic channels, scaffold geometry) to guide the emergence of asymmetric signaling patterns and axis formation.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method generates brain organoids with distinct sub-regions organized in their appropriate anatomical positions, mimicking in vivo topographic organization and enabling precise neuronal connectivity.

Implementation Method 1

the organizer releases the organizing agent to form a gradient concentration of the organizing agent

Methodology Applied
Scientific EffectDiffusion: Diffusion

Data Source

PatentUS12404489B2Establishing topographic organization in three-dimensional tissue culture
Publication Date: 2025.09.02 MEMORIAL SLOAN KETTERING CANCER CENT
  • US12404489B2 patent drawing
  • US12404489B2 patent drawing
  • US12404489B2 patent drawing

AI summary

The present disclosure relates to methods and compositions for generating topographically organized tissues in vitro, for the resulting cultured tissue and components thereof, and for uses of such cultured tissue and its components in drug discovery, toxicology studies, and therapy.